Herpes type-2 viruses and gynaecological malignancies

Area of Science:

• Gynecologic Oncology
• Virology
• Epidemiology

Background:

• Herpes Simplex Virus Type 2 (HSV-2) has been frequently associated with cervical carcinoma in numerous sero-epidemiologic studies.
• The potential role of HSV-2 in other gynecologic malignancies remains an area of investigation.

Purpose of the Study:

• To investigate the association between Herpes Simplex Virus Type 2 (HSV-2) and extra-cervical pelvic malignancies.
• To evaluate the prevalence of HSV-2 antibodies in patients with vulvar cancer and malignant trophoblastic disease.

Main Methods:

• Sero-epidemiologic study comparing antibody prevalence.
• Analysis included patients with extra-cervical pelvic malignancies, chronic cervicitis, and healthy controls in Ibadan.

Main Results:

• No significant difference in the prevalence of HSV-2 antibodies was observed between patients with extra-cervical pelvic malignancies (vulvar cancer, malignant trophoblastic disease) and chronic cervicitis cases.
• The prevalence of HSV-2 antibodies in these patient groups was comparable to that of healthy controls.

Conclusions:

• The study found no evidence to support an association between Herpes Simplex Virus Type 2 (HSV-2) and extra-cervical pelvic malignancies.
• Findings suggest HSV-2 may not play a significant role in the etiology of vulvar cancer or malignant trophoblastic disease.